Global Erythromycin Ethylsuccinate 麻豆原创 Research Report 2023

Publication ID:

PB503232814

Publication Date:

March 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Erythromycin Ethylsuccinate is the ethylsuccinate salt form of erythromycin, a broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin ethylsuccinate diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin ethylsuccinate may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved.
Treatment of acute and chronic vaginal infections eg, vaginitis and vulvo-vaginitis, mixed infections and unspecific infections due to Gardnerella vaginalis, fungal infections caused by Candida albicans, trichomonal infections, and for pre- and postoperative disinfection of the vagina.
Highlights
The global Erythromycin Ethylsuccinate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Erythromycin Ethylsuccinate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Erythromycin Ethylsuccinate is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Erythromycin Ethylsuccinate include Chemenu Inc., Acorn PharmaTech,LLC, BLD Pharm, Boc Sciences and Bide Pharmatech Ltd., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Erythromycin Ethylsuccinate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erythromycin Ethylsuccinate.
The Erythromycin Ethylsuccinate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Erythromycin Ethylsuccinate market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erythromycin Ethylsuccinate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Chemenu Inc.
Acorn PharmaTech,LLC
BLD Pharm
Boc Sciences
Bide Pharmatech Ltd.
Segment by Type
0.1g
0.25g
Segment by Application
Anti-Bacterial Agents
Enzyme Inhibitors
Protein Synthesis Inhibitors
Gastrointestinal Agents
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erythromycin Ethylsuccinate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erythromycin Ethylsuccinate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Erythromycin Ethylsuccinate 麻豆原创 Overview
1.1 Product Overview and Scope of Erythromycin Ethylsuccinate
1.2 Erythromycin Ethylsuccinate Segment by Type
1.2.1 Global Erythromycin Ethylsuccinate 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 0.1g
1.2.3 0.25g
1.3 Erythromycin Ethylsuccinate Segment by Application
1.3.1 Global Erythromycin Ethylsuccinate 麻豆原创 Value by Application: (2023-2029)
1.3.2 Anti-Bacterial Agents
1.3.3 Enzyme Inhibitors
1.3.4 Protein Synthesis Inhibitors
1.3.5 Gastrointestinal Agents
1.4 Global Erythromycin Ethylsuccinate 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Erythromycin Ethylsuccinate Revenue 2018-2029
1.4.2 Global Erythromycin Ethylsuccinate Sales 2018-2029
1.4.3 Global Erythromycin Ethylsuccinate 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Erythromycin Ethylsuccinate 麻豆原创 Competition by Manufacturers
2.1 Global Erythromycin Ethylsuccinate Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Erythromycin Ethylsuccinate Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Erythromycin Ethylsuccinate Average Price by Manufacturers (2018-2023)
2.4 Global Erythromycin Ethylsuccinate Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Erythromycin Ethylsuccinate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erythromycin Ethylsuccinate, Product Type & Application
2.7 Erythromycin Ethylsuccinate 麻豆原创 Competitive Situation and Trends
2.7.1 Erythromycin Ethylsuccinate 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Erythromycin Ethylsuccinate Players 麻豆原创 Share by Revenue
2.7.3 Global Erythromycin Ethylsuccinate 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Erythromycin Ethylsuccinate Retrospective 麻豆原创 Scenario by Region
3.1 Global Erythromycin Ethylsuccinate 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Erythromycin Ethylsuccinate Global Erythromycin Ethylsuccinate Sales by Region: 2018-2029
3.2.1 Global Erythromycin Ethylsuccinate Sales by Region: 2018-2023
3.2.2 Global Erythromycin Ethylsuccinate Sales by Region: 2024-2029
3.3 Global Erythromycin Ethylsuccinate Global Erythromycin Ethylsuccinate Revenue by Region: 2018-2029
3.3.1 Global Erythromycin Ethylsuccinate Revenue by Region: 2018-2023
3.3.2 Global Erythromycin Ethylsuccinate Revenue by Region: 2024-2029
3.4 North America Erythromycin Ethylsuccinate 麻豆原创 Facts & Figures by Country
3.4.1 North America Erythromycin Ethylsuccinate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Erythromycin Ethylsuccinate Sales by Country (2018-2029)
3.4.3 North America Erythromycin Ethylsuccinate Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Erythromycin Ethylsuccinate 麻豆原创 Facts & Figures by Country
3.5.1 Europe Erythromycin Ethylsuccinate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Erythromycin Ethylsuccinate Sales by Country (2018-2029)
3.5.3 Europe Erythromycin Ethylsuccinate Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erythromycin Ethylsuccinate 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Erythromycin Ethylsuccinate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Erythromycin Ethylsuccinate Sales by Country (2018-2029)
3.6.3 Asia Pacific Erythromycin Ethylsuccinate Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erythromycin Ethylsuccinate 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Erythromycin Ethylsuccinate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Erythromycin Ethylsuccinate Sales by Country (2018-2029)
3.7.3 Latin America Erythromycin Ethylsuccinate Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erythromycin Ethylsuccinate 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Erythromycin Ethylsuccinate 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Erythromycin Ethylsuccinate Sales by Country (2018-2029)
3.8.3 Middle East and Africa Erythromycin Ethylsuccinate Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erythromycin Ethylsuccinate Sales by Type (2018-2029)
4.1.1 Global Erythromycin Ethylsuccinate Sales by Type (2018-2023)
4.1.2 Global Erythromycin Ethylsuccinate Sales by Type (2024-2029)
4.1.3 Global Erythromycin Ethylsuccinate Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Erythromycin Ethylsuccinate Revenue by Type (2018-2029)
4.2.1 Global Erythromycin Ethylsuccinate Revenue by Type (2018-2023)
4.2.2 Global Erythromycin Ethylsuccinate Revenue by Type (2024-2029)
4.2.3 Global Erythromycin Ethylsuccinate Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Erythromycin Ethylsuccinate Price by Type (2018-2029)
5 Segment by Application
5.1 Global Erythromycin Ethylsuccinate Sales by Application (2018-2029)
5.1.1 Global Erythromycin Ethylsuccinate Sales by Application (2018-2023)
5.1.2 Global Erythromycin Ethylsuccinate Sales by Application (2024-2029)
5.1.3 Global Erythromycin Ethylsuccinate Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Erythromycin Ethylsuccinate Revenue by Application (2018-2029)
5.2.1 Global Erythromycin Ethylsuccinate Revenue by Application (2018-2023)
5.2.2 Global Erythromycin Ethylsuccinate Revenue by Application (2024-2029)
5.2.3 Global Erythromycin Ethylsuccinate Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Erythromycin Ethylsuccinate Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Chemenu Inc.
6.1.1 Chemenu Inc. Corporation Information
6.1.2 Chemenu Inc. Description and Business Overview
6.1.3 Chemenu Inc. Erythromycin Ethylsuccinate Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Chemenu Inc. Erythromycin Ethylsuccinate Product Portfolio
6.1.5 Chemenu Inc. Recent Developments/Updates
6.2 Acorn PharmaTech,LLC
6.2.1 Acorn PharmaTech,LLC Corporation Information
6.2.2 Acorn PharmaTech,LLC Description and Business Overview
6.2.3 Acorn PharmaTech,LLC Erythromycin Ethylsuccinate Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Acorn PharmaTech,LLC Erythromycin Ethylsuccinate Product Portfolio
6.2.5 Acorn PharmaTech,LLC Recent Developments/Updates
6.3 BLD Pharm
6.3.1 BLD Pharm Corporation Information
6.3.2 BLD Pharm Description and Business Overview
6.3.3 BLD Pharm Erythromycin Ethylsuccinate Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BLD Pharm Erythromycin Ethylsuccinate Product Portfolio
6.3.5 BLD Pharm Recent Developments/Updates
6.4 Boc Sciences
6.4.1 Boc Sciences Corporation Information
6.4.2 Boc Sciences Description and Business Overview
6.4.3 Boc Sciences Erythromycin Ethylsuccinate Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boc Sciences Erythromycin Ethylsuccinate Product Portfolio
6.4.5 Boc Sciences Recent Developments/Updates
6.5 Bide Pharmatech Ltd.
6.5.1 Bide Pharmatech Ltd. Corporation Information
6.5.2 Bide Pharmatech Ltd. Description and Business Overview
6.5.3 Bide Pharmatech Ltd. Erythromycin Ethylsuccinate Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Bide Pharmatech Ltd. Erythromycin Ethylsuccinate Product Portfolio
6.5.5 Bide Pharmatech Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erythromycin Ethylsuccinate Industry Chain Analysis
7.2 Erythromycin Ethylsuccinate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erythromycin Ethylsuccinate Production Mode & Process
7.4 Erythromycin Ethylsuccinate Sales and 麻豆原创ing
7.4.1 Erythromycin Ethylsuccinate Sales Channels
7.4.2 Erythromycin Ethylsuccinate Distributors
7.5 Erythromycin Ethylsuccinate Customers
8 Erythromycin Ethylsuccinate 麻豆原创 Dynamics
8.1 Erythromycin Ethylsuccinate Industry Trends
8.2 Erythromycin Ethylsuccinate 麻豆原创 Drivers
8.3 Erythromycin Ethylsuccinate 麻豆原创 Challenges
8.4 Erythromycin Ethylsuccinate 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Chemenu Inc.
Acorn PharmaTech,LLC
BLD Pharm
Boc Sciences
Bide Pharmatech Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.